Rhythm to Host CEO and CFO Fireside Chats at Two June Healthcare Conferences
RYTM•Rhythm Pharmaceuticals will present at the Jefferies Global Healthcare Conference on June 4 and the Goldman Sachs Annual Global Healthcare Conference on June 8, both via webcast and replay available on the company website for 30 days. CEO David Meeker and CFO Hunter Smith will lead separate fireside chats discussing commercial progress and clinical programs around setmelanotide and earlier-stage MC4R agonists.
1. Conference Participation Details
Rhythm Pharmaceuticals scheduled CFO Hunter Smith for a fireside chat at Jefferies Global Healthcare Conference on June 4 at 12:50 p.m. ET and CEO David Meeker for Goldman Sachs Annual Global Healthcare Conference on June 8 at 1:20 p.m. ET. Both sessions will be webcast live.
2. Webcast Access and Replay
Investors can view live webcasts under “Events & Presentations” on Rhythm’s website; replays will remain available for 30 days post-event. This broadens access for shareholders unable to attend live.
3. Focus on Commercial and Clinical Updates
The sessions are expected to highlight recent commercial performance of IMCIVREE® (setmelanotide) and progress in the company’s clinical pipeline, including investigational MC4R agonists bivamelagon and RM-718.
4. Strategic Investor Engagement
By engaging at top-tier healthcare conferences, Rhythm aims to enhance investor understanding of its rare obesity franchise strategy and upcoming catalysts across regulatory and clinical milestones.
